Skip to main content
TipRanks
Go Ultimate75% OFF

CareCloud (CCLD) AI Stock Analysis

718 Followers
CCLD

CareCloud

(NASDAQ:CCLD)

Select Model
Rating:65Neutral
Price Target:$3.00▲(34.53% Upside)
Action:reiterated
Date:11/06/26

The score is driven primarily by improving financial performance (profitability and strong cash generation) but held back by balance-sheet risk indicated by elevated TTM leverage and some margin volatility. The latest earnings call was a clear positive with record results, margin expansion, and reaffirmed guidance, while technicals are mixed (negative MACD and longer-term averages still overhead). Valuation appears reasonable on P/E, with no dividend support.

Positive Factors
Sustained profitability and revenue growthA long run of profitable periods alongside double-digit revenue growth indicates a meaningful improvement in operating stability and customer demand. This creates a stronger base for reinvestment, supports recurring healthcare IT expansion, and improves the durability of earnings over the coming quarters.
Negative Factors
Elevated balance-sheet leverageThe sharp TTM leverage increase indicates a thinner equity cushion and greater exposure to financing obligations than recent annual periods. Even with recent repayment progress, elevated leverage can constrain investment choices, reduce resilience during execution setbacks, and increase sensitivity to financing costs.

CareCloud (CCLD) vs. SPDR S&P 500 ETF (SPY)

-60%-40%-20%0%20%40%CCLD-22.03%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$94.88M
Dividend Yield
―
Average Volume (3M)
371.44K
Price to Earnings (P/E)
17.3
Beta (1Y)
1.29
Revenue Growth
14.86%
EPS Growth
214.99%
Country
US
Employees
3,650
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

CareCloud Business Overview & Revenue Model

Company Description

CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the...

How the Company Makes Money

CareCloud makes money primarily by selling a combination of (1) subscription software and (2) technology-enabled services to healthcare providers. Key revenue streams generally include: (a) Software/SaaS fees: recurring subscription or usage-based fe...

CareCloud Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:23.89%|Next Earnings Date:Mar 18, 2027
Earnings Call SentimentPositive

The call was strongly positive, led by record profitability, expanding margins, substantial improvement in earnings attributable to common shareholders, debt reduction, strong AI operating metrics, progress in enterprise AI and compliance, and reaffirmed full-year guidance. The company also cited lower medSR project revenue, financing costs, seasonal billing patterns and execution dependencies, but these challenges were limited relative to the breadth of the reported improvements.

Positive Updates

Record Quarterly Profitability
CareCloud reported its most profitable quarter in company history, with record GAAP net income of $4.7 million, up 54% year-over-year; record GAAP EPS of $0.10 versus $0.04; and record adjusted EBITDA of $9.9 million, up 28% year-over-year. The $0.10 earned per share in the quarter matched the amount earned during all of 2025.

Negative Updates

Lower Project-Based Professional Services Revenue
Third-quarter revenue growth benefited from Medsphere, Empower and initial KabaFusion development revenue, but those gains were partially offset by lower project-based professional services revenue at medSR.

Company Guidance

CareCloud reaffirmed its full year 2026 guidance of revenue of $128 million to $132 million, adjusted EBITDA of $29 million to $31 million and GAAP earnings per share of $0.20 to $0.23; management said it was “pretty confident” it would meet all 3, was “on track” for Q4, expected “some seasonality,” and advised investors to be “modest” in their overall perspectives with regard to the 3 factors.

CareCloud Financial Statement Overview

Summary

Income statement and cash flow are solid (recovery to consistent profitability and robust TTM operating/free cash flow), but balance-sheet risk is elevated due to the sharp TTM leverage spike (debt-to-equity ~3.1) and margin volatility versus prior annual levels.

Income Statement

72Positive

Balance Sheet

56Neutral

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue131.30M120.50M110.84M117.06M138.83M139.60M
Gross Profit43.00M56.04M49.99M46.24M54.39M52.68M
EBITDA30.87M28.26M25.37M-30.80M21.62M19.70M
Net Income9.66M10.80M7.85M-48.67M5.43M2.84M
Balance Sheet
Total Assets87.10M87.60M71.61M77.83M136.17M140.85M
Cash, Cash Equivalents and Short-Term Investments4.64M3.12M5.14M3.33M12.30M9.34M
Total Debt42.81M4.28M3.47M14.73M13.81M16.87M
Total Liabilities64.47M28.09M21.84M36.11M34.48M42.92M
Stockholders Equity22.62M59.51M49.77M41.72M101.69M97.93M
Cash Flow
Free Cash Flow26.39M20.53M18.95M3.85M9.38M2.77M
Operating Cash Flow25.00M28.56M20.64M15.46M21.15M13.33M
Investing Cash Flow-8.71M-24.54M-7.41M-11.61M-11.77M-23.15M
Financing Cash Flow-16.78M-5.61M-11.26M-13.29M-7.65M-519.00K

CareCloud Technical Analysis

Technical Analysis SentimentNeutral
Last Price2.23

Price Trends

50DMA2.03Positive
100DMA2.20Positive
200DMA2.45Negative

Market Momentum

MACD0.14Negative
RSI54.21Neutral
STOCH65.18Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Neutral. The current price of 2.23 is above the 20-day moving average (MA) of 2.03, above the 50-day MA of 2.03, and below the 200-day MA of 2.45, indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 54.21 is Neutral, neither overbought nor oversold. The STOCH value of 65.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CCLD.

CareCloud Risk Analysis

CareCloud disclosed 75 risk factors in its most recent earnings report. CareCloud reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The recent cybersecurity incident in our CareCloud Health division could result in material costs, regulatory action and reputational harm.Q2, 2026
2.The use of artificial intelligence by threat actors, and our own development and deployment of AI-enabled products, may increase the risk and potential severity of future cybersecurity incidents.Q2, 2026
3.Geopolitical or economic developments affecting our offshore operations could increase our costs and impair our ability to service client accounts.Q2, 2026

CareCloud Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CCLD against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
WAYWAY76Outperform$5.41B39.863.41%―21.43%9.80%
PHRPHR69Neutral$795.75M73.813.01%―12.93%―
CCLDCCLD65Neutral$94.88M17.2724.48%―14.86%214.99%
EVHEVH58Neutral$546.30M-1.07-129.54%―14.06%-189.46%
AMWLAMWL57Neutral$195.28M-3.30-25.49%―-20.30%52.30%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HCATHCAT51Neutral$105.09M-0.49-128.24%―-13.88%-78.38%

* Healthcare Sector Average

Performance Comparison

0%100%200%CCLDEVHPHRHCATAMWLWAYDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CCLD and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CCLDCarecloud, Inc.2.23-0.75-25.17%
EVHEvolent Health Inc.4.830.8320.75%
PHRPhreesia12.82-6.78-34.59%
HCATHealth Catalyst1.38-0.79-36.41%
AMWLAmerican Well Corporation11.347.32182.09%
WAYWaystar Holding Corp.28.11-6.76-19.39%

CareCloud Corporate Events

Business Operations and StrategyFinancial Disclosures

CareCloud Reports Record Third-Quarter Results and Profitability

Positive
Nov 5, 2026

On November 5, 2026, CareCloud announced record results for the quarter ended September 30, 2026, including revenue of $33.7 million, GAAP net income of $4.7 million, GAAP EPS of $0.10 and adjusted EBITDA of $9.9 million. Year over year, those figure...

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

CareCloud appoints Bonnie Boyer as new CFO

Positive
Sep 29, 2026

On September 29, 2026, CareCloud announced that its Board has promoted Assistant Chief Financial Officer Bonnie Boyer to Chief Financial Officer, effective October 1, 2026, succeeding interim CFO Norman Roth, who will become Advisor to the CEO. Boyer...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026